Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 13

1.

The Impact of the Cellular Origin in Acute Myeloid Leukemia: Learning From Mouse Models.

Fisher JN, Kalleda N, Stavropoulou V, Schwaller J.

Hemasphere. 2019 Jan 30;3(1):e152. doi: 10.1097/HS9.0000000000000152. eCollection 2019 Feb. Review.

2.

Ontogenic Changes in Hematopoietic Hierarchy Determine Pediatric Specificity and Disease Phenotype in Fusion Oncogene-Driven Myeloid Leukemia.

Lopez CK, Noguera E, Stavropoulou V, Robert E, Aid Z, Ballerini P, Bilhou-Nabera C, Lapillonne H, Boudia F, Thirant C, Fagnan A, Arcangeli ML, Kinston SJ, Diop M, Job B, Lecluse Y, Brunet E, Babin L, Villeval JL, Delabesse E, Peters AHFM, Vainchenker W, Gaudry M, Masetti R, Locatelli F, Malinge S, Nerlov C, Droin N, Lobry C, Godin I, Bernard OA, Göttgens B, Petit A, Pflumio F, Schwaller J, Mercher T.

Cancer Discov. 2019 Dec;9(12):1736-1753. doi: 10.1158/2159-8290.CD-18-1463. Epub 2019 Oct 29.

PMID:
31662298
3.

Aggressive leukemia driven by MLL-AF9.

Stavropoulou V, Peters AHFM, Schwaller J.

Mol Cell Oncol. 2017 Oct 23;5(3):e1241854. doi: 10.1080/23723556.2016.1241854. eCollection 2018.

4.

A Novel Inducible Mouse Model of MLL-ENL-driven Mixed-lineage Acute Leukemia.

Stavropoulou V, Almosailleakh M, Royo H, Spetz JF, Juge S, Brault L, Kopp P, Iacovino M, Kyba M, Tzankov A, Stadler MB, Cazzaniga G, Peters AHFM, Schwaller J.

Hemasphere. 2018 Jun 12;2(4):e51. doi: 10.1097/HS9.0000000000000051. eCollection 2018 Aug.

5.

MLL-AF9 Expression in Hematopoietic Stem Cells Drives a Highly Invasive AML Expressing EMT-Related Genes Linked to Poor Outcome.

Stavropoulou V, Kaspar S, Brault L, Sanders MA, Juge S, Morettini S, Tzankov A, Iacovino M, Lau IJ, Milne TA, Royo H, Kyba M, Valk PJM, Peters AHFM, Schwaller J.

Cancer Cell. 2016 Jul 11;30(1):43-58. doi: 10.1016/j.ccell.2016.05.011. Epub 2016 Jun 23.

6.

Estrogen signaling selectively induces apoptosis of hematopoietic progenitors and myeloid neoplasms without harming steady-state hematopoiesis.

Sánchez-Aguilera A, Arranz L, Martín-Pérez D, García-García A, Stavropoulou V, Kubovcakova L, Isern J, Martín-Salamanca S, Langa X, Skoda RC, Schwaller J, Méndez-Ferrer S.

Cell Stem Cell. 2014 Dec 4;15(6):791-804. doi: 10.1016/j.stem.2014.11.002.

7.

Insights into molecular pathways for targeted therapeutics in acute leukemia.

Stavropoulou V, Brault L, Schwaller J.

Swiss Med Wkly. 2010 Sep 9;140:w13068. doi: 10.4414/smw.2010.13068. eCollection 2010. Review.

PMID:
20853191
8.

Functional characterization of high levels of meningioma 1 as collaborating oncogene in acute leukemia.

Liu T, Jankovic D, Brault L, Ehret S, Baty F, Stavropoulou V, Rossi V, Biondi A, Schwaller J.

Leukemia. 2010 Mar;24(3):601-12. doi: 10.1038/leu.2009.272. Epub 2010 Jan 14.

PMID:
20072157
9.

Pseudocyst formation after abdominoplasty in a slim patient.

Stavropoulou V, Vlachos S, Yiacoumettis A.

Plast Reconstr Surg. 2008 Jan;121(1):356-7. doi: 10.1097/01.prs.0000300300.74804.61. No abstract available.

PMID:
18176269
10.
11.

TPPII promotes genetic instability by allowing the escape from apoptosis of cells with activated mitotic checkpoints.

Stavropoulou V, Vasquez V, Cereser B, Freda E, Masucci MG.

Biochem Biophys Res Commun. 2006 Jul 28;346(2):415-25. Epub 2006 Jun 2.

PMID:
16762321
12.

Mitotic infidelity and centrosome duplication errors in cells overexpressing tripeptidyl-peptidase II.

Stavropoulou V, Xie J, Henriksson M, Tomkinson B, Imreh S, Masucci MG.

Cancer Res. 2005 Feb 15;65(4):1361-8.

13.

Supplemental Content

Loading ...
Support Center